Thalia Therapeutics

Be first to know our latest company updates

Watch exclusive videos accompanying major news

Regulatory news

Why Invest

Presentations

Media

AIM Rule 26

Home

Open Sans

THALIA THERAPEUTICS INVESTOR CENTRE

Following on from "Inside N4 Pharma: Our Strategy for the Future", the second video in our Teach-In series explores the fundamentals of RNA therapeutics—what they are, how they work, and why they are transforming modern medicine.

CEO Nigel Theobald explains the role of mRNA and siRNA, the two most prominent RNA-based therapies. He breaks down how mRNA therapeutics help cells produce beneficial proteins, as seen in protein replacement therapy and mRNA vaccines, while siRNA works in the opposite way, blocking the production of harmful proteins—a key approach in cancer treatment and other diseases.

This episode lays the foundation for understanding RNA drug development and sets the stage for the next video, "The Challenges of RNA Delivery", where we’ll explore the hurdles in getting these therapies to the right cells—and how Nuvec® is designed to overcome them.

Watch now and submit your questions below.

RNA Therapeutics: Understanding the Potential